In HNSCC cell lines, foretinib alone strongly inhibited cell growth (cell IC50 0.61–0.79 μM) and exhibited synergistic inhibition of cell proliferation when combined with the EGFR inhibitor erlotinib [117]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.